The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 38.11 USD. With the latest stock price at 24.47 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 55.7%.
Based on the latest price of 24.47 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 55.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.8% | 8.2% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 28.61 - 54.92 | 38.11 |
| Upside | 16.9% - 124.4% | 55.7% |